These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8960070)
21. Territrems B and C metabolism in human liver microsomes: major role of CYP3A4 and CYP3A5. Peng FC; Chang CC; Yang CY; Edwards RJ; Doehmer J Toxicology; 2006 Feb; 218(2-3):172-85. PubMed ID: 16337070 [TBL] [Abstract][Full Text] [Related]
22. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816 [TBL] [Abstract][Full Text] [Related]
23. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Feierman DE; Lasker JM Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601 [TBL] [Abstract][Full Text] [Related]
24. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A. Voorman RL; Maio SM; Hauer MJ; Sanders PE; Payne NA; Ackland MJ Drug Metab Dispos; 1998 Jul; 26(7):631-9. PubMed ID: 9660845 [TBL] [Abstract][Full Text] [Related]
25. Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout. Davis MW; Wason S; Digiacinto JL Consult Pharm; 2013 Mar; 28(3):176-83. PubMed ID: 23462027 [TBL] [Abstract][Full Text] [Related]
26. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. Kobayashi K; Chiba K; Yagi T; Shimada N; Taniguchi T; Horie T; Tani M; Yamamoto T; Ishizaki T; Kuroiwa Y J Pharmacol Exp Ther; 1997 Feb; 280(2):927-33. PubMed ID: 9023308 [TBL] [Abstract][Full Text] [Related]
27. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421 [TBL] [Abstract][Full Text] [Related]
28. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. RamÃrez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333 [TBL] [Abstract][Full Text] [Related]
29. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Hesse LM; Venkatakrishnan K; von Moltke LL; Shader RI; Greenblatt DJ Drug Metab Dispos; 2001 Feb; 29(2):133-40. PubMed ID: 11159802 [TBL] [Abstract][Full Text] [Related]
30. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126 [TBL] [Abstract][Full Text] [Related]
31. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
32. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452 [TBL] [Abstract][Full Text] [Related]
33. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. Gupta RP; Hollis BW; Patel SB; Patrick KS; Bell NH J Bone Miner Res; 2004 Apr; 19(4):680-8. PubMed ID: 15005856 [TBL] [Abstract][Full Text] [Related]
34. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Hijazi Y; Boulieu R Drug Metab Dispos; 2002 Jul; 30(7):853-8. PubMed ID: 12065445 [TBL] [Abstract][Full Text] [Related]
35. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
36. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes. Zhang Y; Guo X; Lin ET; Benet LZ Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971 [TBL] [Abstract][Full Text] [Related]
37. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin. Yamazaki H; Shimada T Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945 [TBL] [Abstract][Full Text] [Related]
38. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428 [TBL] [Abstract][Full Text] [Related]
39. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Fitzsimmons ME; Collins JM Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057 [TBL] [Abstract][Full Text] [Related]
40. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Kerr BM; Thummel KE; Wurden CJ; Klein SM; Kroetz DL; Gonzalez FJ; Levy RH Biochem Pharmacol; 1994 Jun; 47(11):1969-79. PubMed ID: 8010982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]